Siplizumab in T1DM
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Stephen Gitelman, M.D.
University of California San Francisco, School of Medicine: Diabetes Center
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Colorado School of Medicine: Barbara Davis Center for Diabetes
Aurora, Colorado, United States
- University of Iowa Children'S Hospital: Department of Pediatrics, Pediatric Endocrinology and Diabetes
Iowa City, Iowa, United States
- Columbia University Medical Center: Naomi Berrie Diabetes Center
New York, New York, United States
- University of Texas Southwestern Medical Center: Department of Internal Medicine, Division of Endocrinology
Dallas, Texas, United States
- Benaroya Research Institute at Virginia Mason: Diabetes Research Program
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 26 Apr 2023
- Primary completion
- 14 May 2025
- Completion
- 20 Oct 2025
- Last update posted
- 11 Feb 2026
- Registered enrollment
- 8
- Registry id
- NCT05574335
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.